UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): July 8, 2004

 


 

BIO-LOGIC SYSTEMS CORP.

(Exact Name of Registrant as Specified in Charter)

 


 

Delaware   0-12240   36-3025678

(State or Other Jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

One Bio-logic Plaza, Mundelein, IL   60060
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code (847) 949-5200

 



Item 12. Results of Operations and Financial Condition.

 

On July 8, 2004, Bio-logic Systems Corp. issued a press release announcing financial results for the quarter ended May 31, 2004. A copy of this press release is attached hereto as Exhibit 99.1 and the information contained therein is incorporated herein by reference. The information in this Form 8-K (including the exhibit attached hereto) is being furnished under Item 12 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Bio-logic Systems Corp. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

BIO-LOGIC SYSTEMS CORP.
By:  

/s/ Michael J. Hanley


    Corporate Controller and
    Acting Chief Financial Officer

 

Dated: July 8, 2004


Exhibit Index

 

Exhibit
Number


 

Description of Exhibits


99.1   Press Release of Bio-logic dated July 8, 2004.